114849-40-0

Basic information

• Product Name: 2-Pyridinecarboxylic acid, 5-amino-, labeled with tritium (9CI)
• Synonyms: 2-Pyridinecarboxylic acid, 5-amino-, labeled with tritium (9CI)
• CAS NO: 114849-40-0
• Molecular Formula: C6H6N2O2
• Molecular Weight: 0
• Mol File: 114849-40-0.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-Pyridinecarboxylic acid, 5-amino-, labeled with tritium (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyridinecarboxylic acid, 5-amino-, labeled with tritium (9CI)(114849-40-0)
• EPA Substance Registry System: 2-Pyridinecarboxylic acid, 5-amino-, labeled with tritium (9CI)(114849-40-0)

Safety Data

• Hazardous Substances Data: 114849-40-0(Hazardous Substances Data)

Upstream product

• 55338-73-3 5-amino-2-cyanopyridine 
• 59290-34-5 5-nitropyridine-2-carboxamide 
• 4487-59-6 2-bromo-5-nitropyridine 
• 30651-24-2 5-nitropicolinic acid 
• 100367-55-3 5-nitropyridine-2-carbonitrile 
• 4214-76-0 5-nitro-pyridin-2-ylamine 

Downstream Products

• 86873-62-3 5-Acetylaminopyridin-2-carbonsaeure 
• 32046-43-8 5-Iodpicolinsaeure 
• 29082-92-6 5-methoxypyridine-2-carboxylic acid 
• 1561811-30-0 5-((4-(4-(trifluoromethoxy)phenyl)pyrrolo[2,1-f][1,2,4]triazin-2-yl)amino)pyridine-2-carboxylic acid 
• 15069-92-8 5-hydroxypicolinic acid 
• 872355-64-1 1H-pyrrolo[3,2-b]pyridine-5-carboxylic acid 
• 872355-60-7 methyl 5-amino-6-iodopyridine-2-carboxylate 
• 872355-63-0 methyl 1H-pyrrolo[3,2-b]pyridine-5-carboxylate 

Relevant articles and documents

The effect of dye structure on the dyeing and optical properties of dichroic dyes for PVA polarizing film

The dyeing behaviour and optical properties of four novel dyes in PVA polarizing films were determined in terms of the linearity, hydrogen bonding ability, intermolecular interaction and transition moment. The linearity and H-bonding ability of the dyes w

NEW BICYCLIC DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES

The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.

IMIDAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

Novel imidazo[1,2-a]pyrazine compounds are disclosed that have a formula ( I ) represented by the following:The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.